Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Joans Høreklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 3.6% 3.6%   Bankruptcy risk   2.5% 1.8% 3.7% 7.0% 3.1% 2.0% 12.1% 11.8%   Credit score (0-100)   65 72 51 33 56 67 20 20   Credit rating   BBB A BBB BBB BBB A BB BB   Credit limit (kDKK)   0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,714 2,760 2,213 1,983 2,825 2,793 0.0 0.0   EBITDA   647 437 -67.6 -386 629 510 0.0 0.0   EBIT   640 416 -89.1 -407 612 495 0.0 0.0   Pre-tax profit (PTP)   636.9 414.9 -97.4 -423.0 597.0 481.4 0.0 0.0   Net earnings   493.6 322.6 -76.8 -330.9 459.6 373.1 0.0 0.0   Pre-tax profit without non-rec. items   637 415 -97.4 -423 597 481 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   96.7 75.1 53.5 31.9 14.7 0.0 0.0 0.0   Shareholders equity total   743 865 549 37.8 497 721 531 531   Interest-bearing liabilities   0.0 0.0 30.0 99.4 102 152 0.0 0.0   Balance sheet total (assets)   1,482 1,452 1,491 1,178 1,110 1,566 531 531   Net Debt   -878 -821 -902 -400 -652 -627 -531 -531     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,714 2,760 2,213 1,983 2,825 2,793 0.0 0.0   Gross profit growth   42.3% 1.7% -19.8% -10.4% 42.5% -1.1% -100.0% 0.0%   Employees   5 5 5 5 4 4 0 0   Employee growth %   66.7% 0.0% 0.0% 0.0% -20.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,482 1,452 1,491 1,178 1,110 1,566 531 531   Balance sheet change%   62.7% -2.0% 2.6% -21.0% -5.8% 41.2% -66.1% 0.0%   Added value   646.9 437.3 -67.6 -385.8 633.5 509.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   73 -43 -43 -43 -35 -29 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   23.6% 15.1% -4.0% -20.5% 21.7% 17.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   53.5% 28.4% -6.1% -30.5% 53.5% 37.0% 0.0% 0.0%   ROI %   115.7% 49.5% -10.7% -78.7% 136.2% 67.2% 0.0% 0.0%   ROE %   89.9% 40.1% -10.9% -112.8% 171.7% 61.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   50.1% 59.6% 36.8% 3.2% 44.8% 46.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -135.7% -187.8% 1,334.3% 103.5% -103.6% -123.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 5.5% 262.8% 20.6% 21.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 71,833.3% 55.1% 24.2% 15.1% 10.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.7 2.3 1.5 0.9 1.5 1.4 0.0 0.0   Current Ratio   1.8 2.5 1.7 1.1 1.6 1.7 0.0 0.0   Cash and cash equivalent   878.1 821.2 931.7 498.9 754.0 779.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   551.9 755.2 550.2 64.1 376.4 613.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   129 87 -14 -77 158 127 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   129 87 -14 -77 157 127 0 0   EBIT / employee   128 83 -18 -81 153 124 0 0   Net earnings / employee   99 65 -15 -66 115 93 0 0